Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NATALIZUMAB-SZTN for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where NATALIZUMAB-SZTN was used for Relapsing-remitting multiple sclerosis.

Most Reported Side Effects for NATALIZUMAB-SZTN

Side Effect Reports % Deaths Hosp.
Fatigue 63 33.5% 0 3
Mobility decreased 52 27.7% 0 0
Balance disorder 31 16.5% 0 2
Headache 18 9.6% 0 3
Product substitution issue 17 9.0% 2 3
Multiple sclerosis relapse 16 8.5% 0 1
Muscular weakness 16 8.5% 0 0
Cognitive disorder 13 6.9% 0 0
Gait disturbance 13 6.9% 0 0
Dizziness 11 5.9% 0 1
Nausea 9 4.8% 0 0
Urinary incontinence 9 4.8% 0 0
Arthralgia 7 3.7% 0 2
Dysphagia 7 3.7% 0 0
Musculoskeletal stiffness 7 3.7% 0 2

Other Indications for NATALIZUMAB-SZTN

Multiple sclerosis (142) Product used for unknown indication (33)

Other Drugs Used for Relapsing-remitting multiple sclerosis

OCRELIZUMAB (15,658) FINGOLIMOD (8,814) OFATUMUMAB (3,864) DIMETHYL (3,638) NATALIZUMAB (2,749) INTERFERON BETA-1A (2,058) GLATIRAMER (1,965) ALEMTUZUMAB (1,604) TERIFLUNOMIDE (1,320) RITUXIMAB (956)

Related Pages

NATALIZUMAB-SZTN Full Profile All Relapsing-remitting multiple sclerosis Drugs NATALIZUMAB-SZTN Demographics NATALIZUMAB-SZTN Timeline